BIMATOPROST | A202719 | SANDOZ INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| NCMD | 2012-03-13 | Terminated 2015-01-20 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$26.63
per ml
Lowest NADAC/Unit
$20.57
per ml
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00781620693BIMATOPROST 0.03% EYELASH SOLN | $26.63 | ML | Generic | — | 2026-10-21 |
| 00781620675BIMATOPROST 0.03% EYELASH SOLN | $20.57 | ML | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.